• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于最初为 IDH 突变型 2 级的胶质瘤多次复发并接受了 3 次以上连续手术切除后的功能和肿瘤学结果。

Functional and oncological outcomes following more than three consecutive surgical resections for multiple relapses of initially grade 2 IDH-mutated gliomas.

机构信息

Department of Neurosurgery, University of Rouen, Rouen, France.

Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 80 Avenue Augustin Fliche, Montpellier, 34295, France.

出版信息

Acta Neurochir (Wien). 2024 Oct 28;166(1):425. doi: 10.1007/s00701-024-06321-6.

DOI:10.1007/s00701-024-06321-6
PMID:39465448
Abstract

BACKGROUND

Second and third surgeries were demonstrated as safe and efficient in recurrent diffuse low-grade glioma (LGG). Here, the feasibility of more than 3 resections is investigated.

METHODS

Patients who underwent 4 or 5 operations for recurrent initially WHO grade 2 IDH-mutated gliomas were consecutively selected.

RESULTS

Twenty-three operations were performed in five patients (all males, mean age 27.2 ± 4 years). Three patients underwent 5 surgeries and two patients underwent 4 surgeries. Twelve procedures (52%) were achieved with awake mapping, including all 4th and 5th operations but one. Repeat electrical mapping detected changes of the cortical maps between at least two awake surgeries in 4 patients. No patients experienced permanent neurological impairment (KPS score ≥ 80 in all cases). The patients returned to work after 22 surgeries among 23 (95.6%). There were 3 oligodendrogliomas and 2 astrocytomas (4 gliomas became malignant at fourth or fifth operation). Although the preoperative tumor volume significantly increased before the fourth (p = 0.026) and fifth operation (p = 0.003) compared with the first operation, there was no significant difference between the residual tumor volume after the fourth or fifth resection versus the first one. The mean delay was 10.6 ± 3.9 years before chemotherapy and 15.4 ± 3.4 years before radiotherapy (one patient never received adjuvant treatment after 21.5 years). The mean follow-up duration was 18.3 ± 3.1 years since the first surgery (2.3 ± 1.8 years since the last surgery). Three patients were still alive at last follow-up.

CONCLUSIONS

This is the first series showing that to reoperate beyond three times is feasible with a low functional risk and a long survival in multiple LGG recurrences, with the use of awake mapping in 87.5% of 4th and 5th surgeries.

摘要

背景

二次和三次手术已被证明在复发性弥漫性低级别胶质瘤(LGG)中是安全有效的。在此,我们研究了超过 3 次切除的可行性。

方法

连续选择因复发性初始世界卫生组织(WHO)分级 2 型伴 IDH 突变型胶质瘤而接受 4 或 5 次手术的患者。

结果

5 名患者(均为男性,平均年龄 27.2±4 岁)共进行了 23 次手术。其中 3 名患者进行了 5 次手术,2 名患者进行了 4 次手术。12 次手术(52%)采用了清醒脑功能区定位,包括所有第 4 次和第 5 次手术,但有一次除外。4 名患者的重复电刺激脑功能区定位检测到至少两次清醒手术之间皮质映射图的变化。所有患者(KPS 评分均≥80)均未出现永久性神经功能障碍。23 次手术中有 22 次(95.6%)患者术后恢复工作。其中 3 例为少突胶质细胞瘤,2 例为星形细胞瘤(4 例胶质瘤在第 4 或第 5 次手术时发生恶变)。尽管与首次手术相比,第四次(p=0.026)和第五次(p=0.003)手术前的术前肿瘤体积明显增加,但第四次或第五次切除后与首次切除的残余肿瘤体积无显著差异。在化疗前的平均延迟时间为 10.6±3.9 年,在放疗前的平均延迟时间为 15.4±3.4 年(1 例患者在 21.5 年后从未接受过辅助治疗)。自首次手术以来的平均随访时间为 18.3±3.1 年(末次手术以来的随访时间为 2.3±1.8 年)。截至最后随访时,有 3 例患者仍然存活。

结论

这是首次系列研究表明,在多次 LGG 复发中,在功能风险较低的情况下,进行 3 次以上的手术是可行的,并且在 87.5%的第 4 次和第 5 次手术中使用了清醒脑功能区定位。

相似文献

1
Functional and oncological outcomes following more than three consecutive surgical resections for multiple relapses of initially grade 2 IDH-mutated gliomas.对于最初为 IDH 突变型 2 级的胶质瘤多次复发并接受了 3 次以上连续手术切除后的功能和肿瘤学结果。
Acta Neurochir (Wien). 2024 Oct 28;166(1):425. doi: 10.1007/s00701-024-06321-6.
2
Characteristics and Outcomes of Patients With IDH-Mutant Grade 2 and 3 Gliomas After Deferred or Adjuvant Radiotherapy.异柠檬酸脱氢酶(IDH)突变的2级和3级胶质瘤患者延迟放疗或辅助放疗后的特征及预后
Neurology. 2025 Jul;105(1):e213797. doi: 10.1212/WNL.0000000000213797. Epub 2025 Jun 13.
3
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.
4
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
5
Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.术中 5-ALA 荧光引导切除高级别胶质瘤可提高切除程度,改善预后:系统评价。
J Neurooncol. 2022 Jan;156(2):233-256. doi: 10.1007/s11060-021-03901-9. Epub 2022 Jan 6.
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.5-氨基酮戊酸荧光引导切除联合光动力疗法治疗复发性脑胶质瘤的配对队列研究。
Acta Neurochir (Wien). 2024 May 13;166(1):212. doi: 10.1007/s00701-024-06108-9.
8
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
9
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
10
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

引用本文的文献

1
The onco-functional balance in diffuse gliomas: Evolution of the concept over the past decade - And the next steps.弥漫性胶质瘤中的肿瘤功能平衡:过去十年概念的演变——以及下一步。
Brain Spine. 2024 Dec 27;5:104170. doi: 10.1016/j.bas.2024.104170. eCollection 2025.

本文引用的文献

1
Moving towards a connectomic view of neuro-oncology.迈向神经肿瘤学的连接组学视角。
Lancet Neurol. 2024 Jul;23(7):655-656. doi: 10.1016/S1474-4422(23)00291-0.
2
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk-benefit analysis.基于精准肿瘤学时代的分子信息治疗,对复发性神经胶质瘤进行重复手术:风险效益分析。
J Neurooncol. 2024 Apr;167(2):245-255. doi: 10.1007/s11060-024-04595-5. Epub 2024 Feb 9.
3
Brain Plasticity Profiling as a Key Support to Therapeutic Decision-Making in Low-Grade Glioma Oncological Strategies.
脑可塑性分析作为低级别胶质瘤肿瘤学治疗决策的关键支持
Cancers (Basel). 2023 Jul 20;15(14):3698. doi: 10.3390/cancers15143698.
4
Intraoperative functional remapping unveils evolving patterns of cortical plasticity.术中功能重塑揭示皮质可塑性的演变模式。
Brain. 2023 Jul 3;146(7):3088-3100. doi: 10.1093/brain/awad116.
5
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.分子、治疗和患者因素对弥漫性低级别胶质瘤结局的交互作用。
J Clin Oncol. 2023 Apr 10;41(11):2029-2042. doi: 10.1200/JCO.21.02929. Epub 2023 Jan 4.
6
Recurrent insular low-grade gliomas: factors guiding the decision to reoperate.复发性岛叶低级别胶质瘤:指导再次手术决策的因素。
J Neurosurg. 2022 Oct 28;138(5):1216-1226. doi: 10.3171/2022.9.JNS221286. Print 2023 May 1.
7
A Personalized Longitudinal Strategy in Low-Grade Glioma Patients: Predicting Oncological and Neural Interindividual Variability and Its Changes over Years to Think One Step Ahead.低级别胶质瘤患者的个性化纵向策略:预测肿瘤学和神经个体间变异性及其多年来的变化以提前一步思考。
J Pers Med. 2022 Oct 1;12(10):1621. doi: 10.3390/jpm12101621.
8
Repeated Awake Surgical Resection(s) for Recurrent Diffuse Low-Grade Gliomas: Why, When, and How to Reoperate?复发性弥漫性低级别胶质瘤的重复清醒手术切除:为何、何时以及如何再次手术?
Front Oncol. 2022 Jul 5;12:947933. doi: 10.3389/fonc.2022.947933. eCollection 2022.
9
Initial PCV Chemotherapy Followed by Radiotherapy Is Associated With a Prolonged Response But Late Neurotoxicity in 20 Diffuse Low-Grade Glioma Patients.初始PCV化疗后放疗与20例弥漫性低级别胶质瘤患者的反应延长但晚期神经毒性相关。
Front Oncol. 2022 Mar 4;12:827897. doi: 10.3389/fonc.2022.827897. eCollection 2022.
10
Cognitive preservation following awake mapping-based neurosurgery for low-grade gliomas: A longitudinal, within-patient design study.清醒状态下基于神经图谱的低级别胶质瘤手术后认知功能保留:一项前瞻性、单病例研究。
Neuro Oncol. 2022 May 4;24(5):781-793. doi: 10.1093/neuonc/noab275.